SMPD3 and metabolic dysfunction-associated steatotic liver disease: Ceramide homeostasis in LD is regulated in the course of NAFLD by the activation of de novo synthesis in the ER and in situ, on the LD surface by neutral sphingomyelinase 2 (nSMase2).